Works matching AU Gisslinger, H.

Results: 30

Chromosomal abnormalities of young multiple myeloma patients (<45 yr) are not different from those of other age groups and are independent of stage according to the International Staging System.

Published in:

European Journal of Haematology, 2007, v. 78, n. 3, p. 227, doi. 10.1111/j.1600-0609.2006.00807.x

By:

Sagaster, V.;
Kaufmann, H.;
Odelga, V.;
Ackermann, J.;
Gisslinger, H.;
Rabitsch, W.;
Zojer, N.;
Ludwig, H.;
Nösslinger, T.;
Zielinski, C.;
Drach, J.

Publication type:

Article

The effect of interferon alpha on myeloproliferation and vascular complications in polycythemia vera.

Published in:

European Journal of Haematology, 1999, v. 62, n. 1, p. 27, doi. 10.1111/j.1600-0609.1999.tb01110.x

By:

Heis, N.;
Rintelen, C.;
Gisslinger, B.;
Knöbl, P.;
Lechner, K.;
Gisslinger, H.

Publication type:

Article

Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha.

Published in:

Clinical & Experimental Immunology, 1992, v. 90, n. 3, p. 363

By:

Gisslinger, H.;
Gilly, B.;
Woloszczuk, W.;
Mayr, W. R.;
Havelec, L.;
Linkesch, W.;
Weissei, M.

Publication type:

Article

Low Dose Thalidomide in Patients with Relapsed or Refractory Multiple Myeloma.

Published in:

Leukemia & Lymphoma, 2003, v. 44, n. 11, p. 1943, doi. 10.1080/1042819031000123492

By:

Kees, M.;
Dimou, G.;
Sillaber, C.;
Drach, J.;
Ackermann, J.;
Lechner, K.;
Gisslinger, H.

Publication type:

Article

Arsenic Trioxide: Acute Promyelocytic Leukemia and Beyond.

Published in:

Leukemia & Lymphoma, 2002, v. 43, n. 8, p. 1535, doi. 10.1080/1042819021000002857

By:

Bachleitner-Hofmann, T.;
Kees, M.;
Gisslinger, H.

Publication type:

Article

S196: ROPEGINTERFERON ALFA‐2B ACHIEVES PATIENT‐SPECIFIC TREATMENT GOALS IN POLYCYTHEMIA VERA: FINAL RESULTS FROM THE PROUD‐PV/CONTINUATION‐PV STUDIES.

Published in:

HemaSphere, 2022, v. 6, p. 97, doi. 10.1097/01.HS9.0000843676.80508.b5

By:

Gisslinger, H.;
Klade, C.;
Georgiev, P.;
Krochmalczyk, D.;
Gercheva‐Kyuchukova, L.;
Egyed, M.;
Dulicek, P.;
Illes, A.;
Pylypenko, H.;
Sivcheva, L.;
Mayer, J.;
Yablokova, V.;
Empson, V.;
Krejcy, K.;
Hasselbalch, H.;
Kralovics, R.;
Kiladjian, J.‐J.

Publication type:

Article

Treatment with Recombinant Interferon-Alpha-2C: Multiple Myeloma and Thrombocythaemia in Myeloproliferative Diseases.

Published in:

Oncology, 1985, v. 42, n. S1, p. 19, doi. 10.1159/000226080

By:

Ludwig, H.;
Cortelezzi, A.;
Van Camp, B.G.K.;
Polli, E.;
Scheithauer, W.;
Kuzmits, R.;
Linkesch, W.;
Gisslinger, H.;
Sinzinger, H.;
Fritz, E.;
Flener, R.

Publication type:

Article

Endothelial dysfunction in patients with polycythaemia vera.

Published in:

British Journal of Haematology, 2001, v. 115, n. 2, p. 354, doi. 10.1046/j.1365-2141.2001.03092.x

By:

Neunteufl, T.;
Heher, S.;
Stefenelli, T.;
Pabinger, I.;
Gisslinger, H.

Publication type:

Article

Arsenic trioxide and ascorbic acid: synergy with potential implications for the treatment of acute myeloid leukaemia?

Published in:

British Journal of Haematology, 2001, v. 112, n. 3, p. 783, doi. 10.1046/j.1365-2141.2001.02608.x

By:

Bachleitner-Hofmann, T.;
Gisslinger, B.;
Grumbeck, E.;
Gisslinger, H.

Publication type:

Article

Successful re-treatment of an anti-interferon resistant polycythaemia vera patient with lymphoblastoid interferon-αN1 and in vitro studies on the specificity of the antibodies.

Published in:

British Journal of Haematology, 1994, v. 86, n. 1, p. 216, doi. 10.1111/j.1365-2141.1994.tb03283.x

By:

Brand, C. M.;
Leadbeater, L.;
Budiman, R.;
Lechner, K.;
Gisslinger, H.

Publication type:

Article

Treatment and Prophylaxis of Chemotherapy-Induced Gastrointestinal Complaints.

Published in:

Scandinavian Journal of Gastroenterology, 1992, v. 27, n. S191, p. 12, doi. 10.3109/00365529209093224

By:

Kotzmann, H.;
Gisslinger, H.

Publication type:

Article

Dasatinib inhibits progenitor cell proliferation from polycythaemia vera.

Published in:

European Journal of Clinical Investigation, 2008, v. 38, n. 8, p. 578, doi. 10.1111/j.1365-2362.2008.01982.x

By:

Wappl, M.;
Jaeger, E.;
Streubel, B.;
Gisslinger, H.;
Schwarzinger, I.;
Valent, P.;
Oehler, L.

Publication type:

Article

Cytogenetic patterns in multiple myeloma after a phase of preceding MGUS.

Published in:

European Journal of Clinical Investigation, 2008, v. 38, n. 1, p. 53, doi. 10.1111/j.1365-2362.2007.01903.x

By:

Kaufmann, H.;
Ackermann, J.;
Odelga, V.;
Sagaster, V.;
Nösslinger, T.;
Pfeilstöcker, M.;
Keck, A.;
Ludwig, H.;
Gisslinger, H.;
Drach, J.

Publication type:

Article

Allelic imbalance in CALR somatic mutagenesis.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1431, doi. 10.1038/leu.2015.3

By:

Harutyunyan, A S;
Jäger, R;
Chen, D;
Berg, T;
Rumi, E;
Gisslinger, B;
Pietra, D;
Gisslinger, H;
Cazzola, M;
Kralovics, R

Publication type:

Article

Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT).

Published in:

Leukemia (08876924), 2015, v. 29, n. 1, p. 20, doi. 10.1038/leu.2014.250

By:

Barosi, G;
Tefferi, A;
Besses, C;
Birgegard, G;
Cervantes, F;
Finazzi, G;
Gisslinger, H;
Griesshammer, M;
Harrison, C;
Hehlmann, R;
Hermouet, S;
Kiladjian, J-J;
Kröger, N;
Mesa, R;
Mc Mullin, M F;
Pardanani, A;
Passamonti, F;
Samuelsson, J;
Vannucchi, A M;
Reiter, A

Publication type:

Article

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study.

Published in:

Leukemia (08876924), 2013, v. 27, n. 9, p. 1874, doi. 10.1038/leu.2013.163

By:

Tefferi, A;
Rumi, E;
Finazzi, G;
Gisslinger, H;
Vannucchi, A M;
Rodeghiero, F;
Randi, M L;
Vaidya, R;
Cazzola, M;
Rambaldi, A;
Gisslinger, B;
Pieri, L;
Ruggeri, M;
Bertozzi, I;
Sulai, N H;
Casetti, I;
Carobbio, A;
Jeryczynski, G;
Larson, D R;
Müllauer, L

Publication type:

Article

Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria.

Published in:

Leukemia (08876924), 2012, v. 26, n. 4, p. 716, doi. 10.1038/leu.2011.258

By:

Finazzi, G;
Carobbio, A;
Thiele, J;
Passamonti, F;
Rumi, E;
Ruggeri, M;
Rodeghiero, F;
Randi, M L;
Bertozzi, I;
Vannucchi, A M;
Antonioli, E;
Gisslinger, H;
Buxhofer-Ausch, V;
Gangat, N;
Rambaldi, A;
Tefferi, A;
Barbui, T

Publication type:

Article

Rare germline variants in regions of loss of heterozygosity may influence clinical course of hematological malignancies.

Published in:

2011

By:

Harutyunyan, A;
Gisslinger, B;
Klampfl, T;
Berg, T;
Bagienski, K;
Gisslinger, H;
Kralovics, R

Publication type:

Letter

Deletions of the transcription factor Ikaros in myeloproliferative neoplasms.

Published in:

Leukemia (08876924), 2010, v. 24, n. 7, p. 1290, doi. 10.1038/leu.2010.99

By:

Jäger, R.;
Gisslinger, H.;
Passamonti, F.;
Rumi, E.;
Berg, T.;
Gisslinger, B.;
Pietra, D.;
Harutyunyan, A.;
Klampfl, T.;
Olcaydu, D.;
Cazzola, M.;
Kralovics, R.

Publication type:

Article

The ‘GGCC’ haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera.

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1924, doi. 10.1038/leu.2009.110

By:

Olcaydu, D.;
Skoda, R. C.;
Looser, R.;
Li, S.;
Cazzola, M.;
Pietra, D.;
Passamonti, F.;
Lippert, E.;
Carillo, S.;
Girodon, F.;
Vannucchi, A.;
Reading, N. S.;
Prchal, J. T.;
Ay, C.;
Pabinger, I.;
Gisslinger, H.;
Kralovics, R.

Publication type:

Article

Expression of MUM1/IRF4 mRNA as a prognostic marker in patients with multiple myeloma.

Published in:

2008

By:

Heintel, D.;
Zojer, N.;
Schreder, M.;
Strasser-Weippl, K.;
Kainz, B.;
Vesely, M.;
Gisslinger, H.;
Drach, J.;
Gaiger, A.;
Jäger, U.;
Ludwig, H.

Publication type:

Letter

A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group.

Published in:

2007

By:

Barosi, G;
Besses, C;
Birgegard, G;
Briere, J;
Cervantes, F;
Finazzi, G;
Gisslinger, H;
Griesshammer, M;
Gugliotta, L;
Harrison, C;
Hasselbalch, H;
Lengfelder, E;
Reilly, J T;
Michiels, J J;
Barbui, T

Publication type:

Correction Notice

A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group.

Published in:

Leukemia (08876924), 2007, v. 21, n. 2, p. 277, doi. 10.1038/sj.leu.2404473

By:

Barosi, G.;
Besses, C.;
Birgegard, G.;
Briere, J.;
Cervantes, F.;
Finazzi, G.;
Gisslinger, H.;
Griesshammer, M.;
Gugliotta, L.;
Harrison, C.;
Hasselbalch, H.;
Lengfelder, E.;
Reilly, J. T.;
Michiels, J. J.;
Barbui, T.

Publication type:

Article

Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.

Published in:

Leukemia (08876924), 2004, v. 18, n. 11, p. 1879, doi. 10.1038/sj.leu.2403518

By:

Kaufmann, H;
Ackermann, J;
Baldia, C;
Nösslinger, T;
Wieser, R;
Seidl, S;
Sagaster, V;
Gisslinger, H;
Jäger, U;
Pfeilstöcker, M;
Zielinski, C;
Drach, J

Publication type:

Article

Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance.

Published in:

2000

By:

Königsberg, R;
Ackermann, J;
Kaufmann, H;
Zojer, N;
Urbauer, E;
Krömer, E;
Jäger, U;
Gisslinger, H;
Schreiber, S;
Heinz, R;
Ludwig, H;
Huber, H;
Drach, J

Publication type:

journal article

Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis.

Published in:

1998

By:

Weltermann, A;
Pabinger, I;
Geissler, K;
Jäger, U;
Gisslinger, H;
Knöbl, P;
Eichinger, S;
Kyrle, P A;
Valent, P;
Speiser, W;
Schwarzinger, I;
Mannhalter, C;
Lechner, K

Publication type:

journal article

Interferon alpha in the therapy of multiple myeloma.

Published in:

1997

By:

Gisslinger, H.

Publication type:

journal article

Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma.

Published in:

2001

By:

Worel, N.;
Greinix, H.;
Ackermann, J.;
Kaufmann, H.;
Urbauer, E.;
Höcker, P.;
Gisslinger, H.;
Lechner, K.;
Kalhs, P.;
Drach, J.;
Höcker, P

Publication type:

journal article

Ineffectiveness of interferon-γ in the treatment of idiopathic myelofibrosis: a pilot study.

Published in:

Annals of Hematology, 2001, v. 80, n. 2, p. 79, doi. 10.1007/s002770000231

By:

Heis-Vahidi-Fard, N.;
Forberg, E.;
Eichinger, S.;
Chott, A.;
Lechner, K.;
Gisslinger, H.

Publication type:

Article

Fludarabine therapy in Waldenström's macroglobulinemia.

Published in:

2000

By:

Thalhammer-Scherrer, R.;
Geissler, K.;
Schwarzinger, I.;
Chott, A.;
Gisslinger, H.;
Knöbl, P.;
Lechner, K.;
Jäger, U.;
Knöbl, P;
Jäger, U

Publication type:

journal article